Orrstown Financial Services Inc. trimmed its stake in shares of Colgate-Palmolive (NYSE:CL) by 21.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,760 shares of the company’s stock after selling 470 shares during the period. Orrstown Financial Services Inc.’s holdings in Colgate-Palmolive were worth $120,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Vanguard Group Inc. raised its position in shares of Colgate-Palmolive by 1.0% in the 3rd quarter. Vanguard Group Inc. now owns 73,520,894 shares of the company’s stock valued at $4,922,224,000 after buying an additional 734,860 shares in the last quarter. Vanguard Group Inc raised its position in shares of Colgate-Palmolive by 1.0% in the 3rd quarter. Vanguard Group Inc now owns 73,520,894 shares of the company’s stock valued at $4,922,224,000 after buying an additional 734,860 shares in the last quarter. BlackRock Inc. raised its position in shares of Colgate-Palmolive by 13.5% in the 4th quarter. BlackRock Inc. now owns 60,648,605 shares of the company’s stock valued at $3,609,804,000 after buying an additional 7,236,342 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Colgate-Palmolive by 3.2% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 32,521,377 shares of the company’s stock valued at $1,935,674,000 after buying an additional 1,000,161 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Colgate-Palmolive by 1.1% in the 3rd quarter. Bank of New York Mellon Corp now owns 20,359,199 shares of the company’s stock valued at $1,363,050,000 after buying an additional 223,814 shares in the last quarter. Institutional investors and hedge funds own 76.22% of the company’s stock.
Colgate-Palmolive stock opened at $71.30 on Friday. The company has a debt-to-equity ratio of 32.25, a quick ratio of 0.76 and a current ratio of 1.14. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $71.50. The firm has a market cap of $61.30 billion, a P/E ratio of 24.01, a P/E/G ratio of 4.53 and a beta of 0.79.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be issued a $0.43 dividend. The ex-dividend date is Wednesday, April 17th. This represents a $1.72 annualized dividend and a dividend yield of 2.41%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.42. Colgate-Palmolive’s dividend payout ratio is currently 57.91%.
A number of equities analysts recently issued reports on the stock. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Tuesday. UBS Group upped their price objective on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the stock a “buy” rating in a research report on Friday, March 29th. Citigroup set a $68.00 price objective on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research report on Tuesday, March 19th. Credit Suisse Group began coverage on shares of Colgate-Palmolive in a report on Wednesday, March 6th. They set an “underperform” rating on the stock. Finally, BNP Paribas raised shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and boosted their target price for the stock from $56.00 to $67.00 in a report on Monday, February 11th. Three equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have given a buy rating to the company. Colgate-Palmolive currently has a consensus rating of “Hold” and an average price target of $65.73.
In related news, CEO Ian M. Cook sold 22,634 shares of the stock in a transaction dated Tuesday, February 19th. The shares were sold at an average price of $66.31, for a total transaction of $1,500,860.54. Following the completion of the transaction, the chief executive officer now owns 1,162,793 shares in the company, valued at $77,104,803.83. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director John T. Cahill sold 5,780 shares of the stock in a transaction dated Thursday, January 31st. The shares were sold at an average price of $64.46, for a total transaction of $372,578.80. Following the transaction, the director now owns 27,820 shares of the company’s stock, valued at approximately $1,793,277.20. The disclosure for this sale can be found here. In the last quarter, insiders sold 103,200 shares of company stock valued at $6,900,449. 1.14% of the stock is currently owned by corporate insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Recommended Story: Gap Up Stocks
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.